Bayer AG/ DE000BAY0017 /
6/16/2025 5:36:15 PM | Chg. +0.08 | Volume | Bid5:36:15 PM | Ask5:36:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
27.57EUR | +0.29% | 1.07 mill. Turnover: 15.22 mill. |
-Bid Size: - | -Ask Size: - | 27.09 bill.EUR | 0.40% | - |
GlobeNewswire
6/4
LIfT BioSciences joins Bayer Co.Lab Cambridge, securing access to cutting-edge lab facilities
GlobeNewswire
5/27
AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Partic...
GlobeNewswire
5/19
AskBio Presents Complete Results of Phase 1 Trial of AB-1002 Gene Therapy in Participants with Conge...
GlobeNewswire
5/8
AskBio Announces 15 Presentations at American Society of Gene and Cell Therapy 28th Annual Meeting
GlobeNewswire
5/8
Sibylla Biotech Appoints Former Bayer CEO, Dieter Weinand, as Chairman of the Board of Directors
GlobeNewswire
4/25
Freight Technologies Integrates with Blue Yonder TMS Through Bayer to Optimize Supply Chain Efficien...
GlobeNewswire
4/16
BlueRock Therapeutics announces publication in Nature of 18-month data from Phase 1 clinical trial f...
GlobeNewswire
3/7
AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosin...
GlobeNewswire
2/27
UPDATE - YourUpdateTV Speaks with Alanna Morris-Simon from Bayer to Discuss Key Risk Factors for Hea...
GlobeNewswire
2/24
YourUpdateTV Speaks with Alanna Morris-Simon from Bayer to Discuss Key Risk Factors for Heart Diseas...
GlobeNewswire
2/19
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease inves...